autologous cervical cancer-specific engineered immune effector cells
Term · Oncology and biomedicine · MLC-T-ONC-011569
A preparation of autologous immune effector cells genetically modified to target a not yet disclosed cervical cancer-specific tumor-associated antigen (TAA), with potential immunomodulating and antineoplastic activities. After isolation, transduction, expansion in culture, and reintroduction into the patient, the autologous cervical cancer-specific engineered immune effector (CC-EIE) cells bind to and induce selective toxicity in tumor cells expressing the TAA.
| Identifier | MLC-T-ONC-011569 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous CC-EIEs; autologous CC-EIE cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011569",
"term": "autologous cervical cancer-specific engineered immune effector cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous immune effector cells genetically modified to target a not yet disclosed cervical cancer-specific tumor-associated antigen (TAA), with potential immunomodulating and antineoplastic activities. After isolation, transduction, expansion in culture, and reintroduction into the patient, the autologous cervical cancer-specific engineered immune effector (CC-EIE) cells bind to and induce selective toxicity in tumor cells expressing the TAA.",
"synonyms": [
"autologous CC-EIEs",
"autologous CC-EIE cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-cervical-cancer-specific-engineered-immune-effector-cells/"
}
Record 2,903 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.